Lemonade Soars 15.8% on Morgan Stanley Upgrade 03/18/26

Lemonade Soars 15.8% on Morgan Stanley Upgrade 03/18/26 Key Stories: Billionaire investor Chase Coleman is making a clear bet on artificial intelligence, with his hedge fund dedicating a substantial 20% of its portfolio to just two key AI stocks. Those are Alphabet, parent company of Google and a major player in AI research and cloud computing, and Microsoft, the software giant that has heavily invested in OpenAI and integrated AI across its products. This significant allocation from a prominent institutional investor highlights the ongoing confidence in these tech titans as long-term beneficiaries of the AI revolution, suggesting their foundational role in the evolving technological landscape continues to attract serious capital. Investors often watch such large-scale institutional moves for conviction signals. Read more Shifting gears to another stock making big moves: Lemonade, the insurance technology company, saw its shares surge by a remarkable 15.81% yesterday, closing at $66.87. This marks the third straight day of gains for the insurtech firm. The significant rally came after investment bank Morgan Stanley upgraded its rating and price target on Lemonade, signaling increased confidence in the company’s growth prospects. Such a strong endorsement from a major firm can often spark significant buying interest, as investors react positively to updated outlooks and potential for future appreciation in the relatively nascent insurtech sector. Read more On the downside today, global pharmaceutical powerhouse Eli Lilly experienced a noticeable drop, with its shares falling 6.3% in afternoon trading. This decline followed investment bank HSBC’s decision to downgrade Eli Lilly’s stock to a “reduce” rating, which is equivalent to a sell, from its previous “hold” recommendation. HSBC cited concerns that the stock was “priced to perfection,” suggesting that its valuation might have gotten ahead of its fundamentals, leaving little room for error or further upside. This move highlights how even strong companies can face pressure when analysts perceive their market value to be overly optimistic, prompting investors to re-evaluate their positions. Read more Keywords: ” pharmaceutical, “priced to perfection, AI stocks, Alphabet, Eli Lilly, GOOGL, HSBC, LLY, LMND, Lemonade, MSFT, Microsoft, Morgan Stanley, cloud computing, fintech, hedge fund, institutional investment, insurtech, price target, rating upgrade, stock downgrade, stock surge, technology, valuation concernsThe post Lemonade Soars 15.8% on Morgan Stanley Upgrade 03/18/26 first appeared on Rapid Money Radio.